Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

AKTX Akari Therapeutics PLC

0,97

-0,0299 (-2,99%)

21 Dez 2024 - Geschlossen

Verzögert um 15 Minuten

Form 424B3 - Prospectus [Rule 424(b)(3)]

Article too big to display. Click here to view on the SEC website

Akari Therapeutics (NASDAQ:AKTX)
Historical Stock Chart
Von Nov 2024 bis Dez 2024

Click Here for more Akari Therapeutics Charts.

Akari Therapeutics (NASDAQ:AKTX)
Historical Stock Chart
Von Dez 2023 bis Dez 2024

Click Here for more Akari Therapeutics Charts.

News Akari Therapeutics PLC

Form 3 - Initial statement of beneficial ownership of securities
Freitag 20 Dezember 2024 (17 Stunden vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 18 Dezember 2024 (3 Tage vor) • Edgar (US Regulatory)

Akari Therapeutics Announces Key Leadership Appointments
Mittwoch 18 Dezember 2024 (3 Tage vor) • GlobeNewswire Inc.

Form 8-K - Current report
Montag 16 Dezember 2024 (5 Tage vor) • Edgar (US Regulatory)

Akari Therapeutics Appoints Torsten Hombeck, Ph.D. as Chief Financial Officer
Montag 16 Dezember 2024 (5 Tage vor) • GlobeNewswire Inc.

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Freitag 6 Dezember 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 3 Dezember 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 3 Dezember 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Freitag 22 November 2024 (4 Wochen vor) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Freitag 22 November 2024 (4 Wochen vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Dienstag 19 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 19 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Weitere Akari Therapeutics PLC News-Artikel

Kingdom of Spain

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen